Prosecution Insights
Last updated: October 27, 2026

Tammie K Marlen, USPTO Patent Examiner

Listed by the USPTO as MARLEN, TAMMIE K

Tech Center 3700 • Art Units: 3700 3762 3766 3792 3796

This examiner grants 75% of resolved cases

Analysis

MARLEN, TAMMIE K is assigned to tech center 3700 and art unit 3700. The profile covers 818 resolved cases, with a 75.3% allowance rate and a 20.8% interview lift. The median time to allowance is 1374 days, indicating that successful prosecution can still involve extended pendency.

Listed company activity includes Biotronik SE & Co. KG, Boston Scientific Corporation, and Oura Health Oy. The listed firms are BUCHANAN INGERSOLL & ROONEY PC, ARENTFOX SCHIFF LLP, and BOTOS CHURCHILL IP LAW LLP-ABIO. Applicants in this docket may find interview practice relevant when developing prosecution strategy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

75.3%
Allow Rate
+5.3% vs TC avg
882
Total Applications
+20.8%
Interview Lift
1374
Avg Prosecution Days
Based on 818 resolved cases, 2023–2026

Rejection Statute Breakdown

5.7%
§101 Eligibility
31.0%
§102 Novelty
28.4%
§103 Obviousness
30.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18668615 IMPLANTABLE MEDICAL DEVICE INCLUDING ELECTRODES FORMED THEREIN Non-Final OA Cardiac Pacemakers, Inc.
18294493 PARAMETER VARIATIONS IN NEURAL STIMULATION Final Rejection Cala Health, Inc.
17609160 DEVICES AND METHODS FOR TREATING TINNITUS USING ELECTRICAL STIMULATION Final Rejection Mayo Foundation for Medical Education and Research
18447067 WEARABLE RING DEVICE FOR ON-THE-GO CHARGING Non-Final OA Oura Health Oy
18155467 WEARABLE DEVICES Final Rejection Oura Health Oy
18681160 Sensing System for Sensing Biological Signals Externally on a Patient Non-Final OA BIOTRONIK SE & Co. KG
18292113 Braid-Supported Helical Leads for Implantable Electrode Leads Final Rejection BIOTRONIK SE & Co. KG
18263728 5G Implant with Predetection and/or with a 5G Modem Non-Final OA BIOTRONIK SE & CO. KG
18287094 Closed-Loop Neuromodulation for the Treatment of Affective Neuropsychiatric Disorders Final Rejection The Regents of the University of California
19053650 DUAL LUMEN SHEATH FOR ARTERIAL ACCESS Non-Final OA ABIOMED, Inc.
18807096 PURGE-FREE MINIATURE ROTARY PUMP Non-Final OA ABIOMED, Inc.
18682343 DEVICES WITH INTEGRATED CONCAVE COILS Non-Final OA Cochlear Limited
18461957 IN-BAND TELEMETRY FOR DEVICE LONGEVITY Final Rejection Medtronic, Inc.
18548621 SKIN-ADHERENT, ULTRA-STRETCHABLE, AND CONFORMAL WEARABLE ELECTROCARDIOGRAPHIC DEVICE AND FABRICATION METHOD Final Rejection The Hong Kong University of Science and Technology
18646637 METHODS AND DEVICES FOR TREATING PELVIC CONDITIONS Non-Final OA HOLOGIC, INC.
17791523 WEARABLE CHRONIC MONITORING SYSTEMS, METHODS, AND DEVICES Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
18326407 HERMETIC FEEDTHROUGH ASSEMBLY AND ASSOCIATED METHODS Final Rejection Pacesetter, Inc.
19171993 NEUROSTIMULATION SYSTEMS USING SENSE AND OUTCOMES DATA Non-Final OA Boston Scientific Neuromodulation Corporation
18540469 CONNECTOR CONTACT FOR ELECTRICAL STIMULATION SYSTEM Final Rejection Boston Scientific Neuromodulation Corporation
19098758 ALERT BUTTON TRAINING SYSTEM FOR A WEARABLE MEDICAL DEVICE AND METHOD THEREOF Non-Final OA WEST AFFUM HOLDINGS DAC
18063464 COMPRESSION GARMENT ASSEMBLY FOR APPLYING TTFIELDS AND METHODS OF PRODUCTION AND USE THEREOF Final Rejection Novocure GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Tammie K Marlen's allowance rate?

75.3% of resolved applications examined by Tammie K Marlen were allowed (818 resolved cases), compared with 66.1% across Art Unit 3700 over the last five years.

Does an interview help with examiner Tammie K Marlen?

This examiner's interview lift is +20.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Tammie K Marlen take to allow a patent?

Applications allowed by Tammie K Marlen took 1,374 days on average from filing to allowance.

Which art unit does examiner Tammie K Marlen work in?

Tammie K Marlen examines applications in Art Unit 3700 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month